Akèy › Timè nan sèvo › Ohio › Cleveland
Etid klinik pou Timè nan sèvo nan Cleveland, OH
11 etid pou Timè nan sèvo ap chèche patisipan nan sit nan ak bò kote Cleveland (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
Ap rekriteFaz 2
- Cleveland Clinic Taussig Cancer Center, Cleveland
Memory Avoidance Whole Brain Radiotherapy vs Hippocampal Avoidance Whole Brain Radiotherapy (Athena 2 Trial)
Ap rekriteFaz 2
- University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Ap rekriteFaz 1/2
- Cleveland Clinic, Cleveland
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
Ap rekriteFaz 2
- Case Western Reserve University, Cleveland
- UHHS-Chagrin Highlands Medical Center, Beachwood · 10 mi lwen
Development of MRF for Characterization of Brain Tumors After Radiotherapy
Ap rekriteVolontè an sante akeyi
- University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center, Cleveland
- Cleveland Clinic Taussig Cancer Center, Cleveland
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Ap rekriteFaz 1
- University Hospital Cleveland Medical Center, Cleveland
- Cleveland Clinic, Cleveland
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
Ap rekriteFaz 1/2
- Cleveland Clinic, Case Comprehensive Cancer Center, Cleveland
A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas
Ap rekriteFaz 2
- Case Comprehensive Cancer Center, Cleveland Clinic Foundation Taussig Cancer Institute, Cleveland
REMASTer: REcurrent Brain Metastases After SRS Trial
Ap rekrite
- Cleveland Clinic, Cleveland
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Cleveland Clinic, Cleveland
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
Ap rekriteFaz 3
- Case Western Reserve University, Cleveland
- Cleveland Clinic Cancer Center/Fairview Hospital, Cleveland
- Cleveland Clinic Foundation, Cleveland
- ak 3 plis
Etid Timè nan sèvo nan lòt vil
- Houston, TX35 etid
- Boston, MA28 etid
- New York City, NY25 etid
- Washington, DC20 etid
- Los Angeles, CA16 etid
- Miami, FL15 etid
- Durham, NC14 etid
- St. Louis, MO12 etid
- Seattle, WA11 etid
- Rochester, MN11 etid
- Baltimore, MD11 etid
- Columbus, OH11 etid
Lòt etid nan Cleveland
- Kansè Poumon ki pa ti selil43 etid
- Kansè (tout kalite)36 etid
- Kansè nan tete35 etid
- Kansè pwostat34 etid
- Ensifizyans kadyak33 etid
- Kansè Metastatik30 etid
- Kansè ovè30 etid
- Kansè poumon26 etid
- Kansè kolorektal24 etid
- Maladi kadyovaskilè22 etid
- Kansè Endomèt20 etid
- Leksemi mieloïd egi20 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.